Femoral Artery Clinical Trials

2 recruiting

Frequently Asked Questions

Common questions about Femoral Artery clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Not Applicable

Effect of a Sacral Lift on Femoral Vein Size and Exposure

Femoral ArteryCannulation
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)35 enrolled1 locationNCT06916741
Recruiting
Not Applicable

Contribution of Optical Coherence Tomography in the Endovascular Treatment of Femoral Occlusions

ClaudicationSuperficial Femoral Artery StenosisIschemic Leg
University Hospital, Lille166 enrolled1 locationNCT04434586
Recruiting
Not Applicable

Shockwave™ vs Surgical Endarterectomy for Calcified Severe Common Femoral Artery Stenosis: Comparison of Efficacy, Safety and Long-Term Outcomes

Calcification; HeartCommon Femoral Artery Stenosis
Baylor Research Institute60 enrolled1 locationNCT06829914
Recruiting
Not Applicable

First In Human Study to Assess Safety and Efficacy of the ChampioNIR™ Drug Eluting Peripheral Stent in the Treatment of Patients With Superficial Femoral Artery Disease and/or Proximal Popliteal Artery Disease

Superficial Femoral Artery StenosisPopliteal Artery Stenosis
Medinol Ltd.30 enrolled7 locationsNCT06410313
Recruiting
Not Applicable

STAR-PAK Study: Evaluating the Safety and Efficacy of PAK® (Paclitaxel Coated Balloon) in Treating Atherosclerotic Femoro-Popliteal Lesions

Peripheral Artery DiseaseSuperficial Femoral Artery StenosisPopliteal Artery Stenosis Above the Knee
Balton Sp.zo.o.120 enrolled3 locationsNCT06734221
Recruiting

European All-comers' Multicentric Prospective REGISTRY on LUMINOR© Drug Eluting Balloon in the Superficial Femoral Artery and Popliteal Artery With 5 Years Follow-up.

Peripheral Arterial DiseasePaclitaxelAngioplasty+2 more
iVascular S.L.U.500 enrolled15 locationsNCT04743180
Recruiting
Early Phase 1

The Tetherx Natural Vascular Scaffolding (NVS) Procedure for Treating Patients with Atherosclerosis of the Femoropopliteal Artery

Symptoms of claudication or ischemic rest pain (Rutherford category 2, 3, or 4) with suspected atherosclerosis in either the superficial femoral artery or the proximal popliteal artery (above the knee articulation).
Tetherx, Inc.30 enrolled1 locationACTRN12611000897965